Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 1.9B | 1.7B | 2.0B | 2.0B |
Cost of revenue | 1.4B | 1.2B | 1.5B | 1.4B |
Gross profit | 510M | 451M | 543M | 518M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 293M | 279M | 274M | 268M |
Other operating expenses | — | — | — | — |
Operating income | 171M | 124M | 223M | 204M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 30M | 36M | 36M | 36M |
Other income expense | — | — | — | — |
Pretax income | 141M | 88M | 187M | 168M |
Tax provision | 36M | 21M | 47M | 42M |
Net income | 105M | 67M | 140M | 126M |
Basic EPS | 0.5 | 0.3 | 0.7 | 0.6 |
Diluted EPS | 0.5 | 0.3 | 0.7 | 0.6 |
Basic average shares | 189.8M | 190.1M | 191.5M | 192.8M |
Diluted average shares | 198.7M | 199.5M | 201.2M | 202.7M |
EBITDA | 219M | 174M | 272M | 253M |
Net income from continuing op. | 105M | 67M | 140M | 126M |
Minority interests | -5M | -3M | -7M | -7M |
Preferred stock dividends | — | — | — | — |